Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration

Documenta Ophthalmologica

Volumn 106, Issue 2, 2003, Pages 129-136

  Evereklioglu, Cem ^a   Er, Hamdi ^b   Doganay, Selim ^b   Cekmen, Mustafa ^c   Turkoz, Yusuf ^b   Otlu, Baris ^b   Ozerol, Elif ^b  

^a ERCIYES UNIVERSITY   (Turkey)

^b INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Age related macular degeneration; Antioxidant enzymes; Lipid peroxidation; Nitric oxide

Indexed keywords

CATALASE; FREE RADICAL; GLUTATHIONE PEROXIDASE; LIPID; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ADULT; AGE; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CATALYSIS; CELL LEVEL; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERYTHROCYTE; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PLASMA; PREVALENCE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY;

AGED; ANTIOXIDANTS; CATALASE; CROSS-SECTIONAL STUDIES; DOUBLE-BLIND METHOD; ERYTHROCYTES; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; LIPID PEROXIDATION; MACULAR DEGENERATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 0037343994     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022512402811     Document Type: Article

References (36)

1. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy. Ophthalmology 1997; 104: 7-21.
2. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration: The International ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39: 367-74.
3. Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol 1992; 110: 1701-8.
4. Christen WG Jr. Antioxidants and eye disease. Am J Med 1994; 97: 14-7.
5. Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, De Jong PT. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 1995; 142: 404-9.
6. Allikmets R, Shroyer NF, Singh N, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997; 277: 1805-7.
7. Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: The Blue Mountains Eye Study. Arch Ophthalmol 1998; 116: 583-7.
8. Gerster H. Review: Antioxidant protection of the ageing macula. Age Ageing 1991; 20: 60-9.
9. Pastor MC, Sierra C, Dolade M, et al. Antioxidant enzymes and fatty acid status in erythrocytes of Down's syndrome patients. Clin Chem 1998; 44: 924-9.
10. Ben-Menachem E, Kyllerman M, Marklund S. Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies. Epilepsy Res 2000; 40: 33-9.
11. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998; 78: 547-81.
12. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527-605.
13. Sozmen EY, Kerry Z, Uysal F, et al. Antioxidant enzyme activities and total nitrite/nitrate levels in the collar model. Effect of nicardipine. Clin Chem Lab Med 2000; 38: 21-5.
14. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial cell injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-4.
15. Hirvela H, Luukinen H, Laara E, Laatikainen L. Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 1996; 103: 871-7.
16. Klein R, Davis M, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991; 98: 1128-34.
17. Granger DL, Taintor RR, Boockvar KS, Hibbs JB Jr. Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol 1996; 268: 142-51.
18. Evereklioglu C, Turkoz Y, Er H, Inaloz HS, Ozbek E, Cekmen M. Increased serum nitric oxide levels in patients with Behçet's disease: Is it a new activity marker? J Am Acad Dermatol 2002; 46: 50-4.
19. Wasowics W, Neve J, Peretz A. Optimized steps in flourometric determination of thiobarbituric acid-reactive substances in serum: Importance of extraction pH and influence of sample preservation and storage. Clin Chem 1993; 39: 2522-6.
20. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
21. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967: 70: 158-69.
22. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-6.
23. Lowry OH, Rosenbrough NJ, Farr AL. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
24. Tso MO. Retinal photic injury in normal and scorbutic monkeys. Trans Am Ophthalmol Soc 1987; 85: 498-556.
25. Alexander LJ. Age-related macular degeneration: The current understanding of the status of clinicopathology, diagnosis and management. J Am Optom Assoc 1993; 64: 822-37.
26. Crastes De Paulet A. Free radicals and aging. Ann Biol Clin 1990; 48: 323-30.
27. Cai J, Nelson KC, Wu M, Sternberg P Jr, Jones DP. Oxidative damage and protection of the RPE. Prog Retin Eye Res 2000; 19: 205-21.
28. Halliwell B. Reactive oxygen species in living systems: Source, biochemistry, and role in human disease. Am J Med 1991; 91: 14-22.
29. Guemouri L, Artur Y, Herbeth B, Jeandel C, Siest G. Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Clin Chem 1991; 37: 1932-7.
30. Goldstein IM, Ostwald P, Roth S. Nitric oxide: A review of its role in retinal function and disease. Vision Res 1996; 36: 2979-94.
31. Muijsers RB, Folkerts G, Henricks PA, Sadeghi-Hashjin G, Nijkamp FP. Peroxynitrite: A two-faced metabolite of nitric oxide. Life Sci 1997; 60: 1833-45.
32. Beckman JS. The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol 1991; 15: 53-9.
33. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990; 347: 768-70.
34. Goureau O, Jeanny JC, Becquet F, Hartmann MP, Courtois Y. Protection against light-induced degeneration by an inhibitor of NO synthase. Neuroreport 1993; 5: 233-6.
35. De La Paz M, Anderson RE. Region and age-dependent variation in susceptibility of the human retina to lipid peroxidation. Invest Ophthalmol Vis Sci 1992; 33: 3497-9.
36. Wassell J, Davies S, Bardsley W, Boulton M. The photoreactivity of the retinal age pigment lipofuscin. J Biol Chem 1999; 274: 23828-32.